Chennai, Tamil Nadu
GST No. 33ACGPF5198L1ZB
Call 08047636743 85% Response Rate
Send Enquiry
| Packaging Size | 21 Capsule |
| Brand | Pomid |
| Composition | Pomolidamide |
| Manufacturer | Hetero |
| Prescription/Non prescription | Prescription |
| Strength | 4mg |
View Complete details
Minimum Order Quantity: 1 Box
| Manufacturer | MSD |
| Prescription/Non prescription | Prescription |
| Packaging Size | 100 |
| Brand | EUDAXEN |
| Composition | Diazoxide capsules |
| Treatment | LOW BLOOD SUGAR |
| Deals in | Third Party Manufacturing |
| Form | CAPSULES |
| Country of Origin | Made in India |
Additional Information:
View Complete details
| Strength | 50 mg |
| Form | Capsules |
| Composition | Diazoxide capsules |
| Packaging Size | 100 |
| Brand | eudaxen |
View Complete details
Minimum Order Quantity: 1 Box
| Strength | 50 mg |
| Form | Tablets |
| Composition | DIAZOXIDE |
| Packaging Size | 50MG |
| Packaging Type | BOX |
Additional Information:
View Complete details
Minimum Order Quantity: 1 Pack
| Usage | Clinical,Hospital |
| Dose/Strength (ex. 1 mg or 1 ml) | 250 mg |
| Packaging Size | 120 Tablet |
| Packaging Type | Box |
| Brand | Xbira |
Other Details:
Pharmacy Medicine
Keep out of reach of children
For Oral Use
View Complete details
Minimum Order Quantity: 2 Box
| Dose/Strength | 100mg 400mg |
| Type | Allopathic |
| Category | Blood Cancer |
| Product Type | Finished Product |
| Gender | Unisex |
| Usage | Hospital |
Additional Information:
View Complete details
Minimum Order Quantity: 1 Pack
| Dose/Strength | 250mg 500mg |
| Dosage Form | Tablet |
| Form of Medicine | Tablet |
| No of tablets | 120 |
| Composition | Abiraterone Acetate |
| Drug Name | Abiraterone Acetate |
| Packaging Type | Bottle |
| Gender | Unisex |
| Brand | BDRON |
| Usage | Personal |
Abiraterone works by reducing androgen production in the body. Androgens are male hormones that can promote tumor growth in the prostate gland.
WHAT IS THE USE OF BDRON 250MG TABLETS ?Bdron is used together with prednisone to treat prostate cancer that has spread to other parts of the body.
WHAT ARE THE POSSIBLE SIDE-EFFECTS OF BDRON 250MG TABLETS ?Stop using Bdron and call your doctor at once if you have:
swelling in your ankles or feet, pain in your legs; pain or burning when you urinate; dangerously high blood pressure - severe headache, blurred vision, pounding in your neck or ears, nosebleed, anxiety, severe chest pain, shortness of breath;
liver problems - nausea, upper stomach pain, itching, tired feeling, loss of appetite, dark urine, clay-colored stools, jaundice;
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects.
Additional Information:
View Complete details
Minimum Order Quantity: 1 Box
| Manufacturer | GLENMARK |
| Prescription/Non prescription | Prescription |
| Form | Capsule |
| Packaging Type | Strip |
| Packaging Size | 28 CAPSULES PER BLISTER |
| Brand | GLENZA |
| Composition | ENZALUDAMIDE 40 MG |
| Storage Condition | It is stored in room temperature (20-25 DegreeC) |
| Treatment | CANCER |
amide is a prescription medicine used to treat prostate cancer in men who have received surgery or hormone therapy to lower testosterone.
Enzalutamide is sometimes used when the cancer no longer responds to treatment, but has not spread to other parts of the body.
Enzalutamide is also used to when the cancer has responded to treatment and has spread to other parts of the body (metastatic).
It is not known if enzalutamide is safe and effective in in childre or females
Additional Information:
View Complete details
Minimum Order Quantity: 1 Box
| Prescription/Non prescription | Prescription |
| Packaging Type | Box |
| Packaging Size | 40 mg |
| Form | Capsules |
| Composition | Enzalutamide |
| Dosage Form | Oral |
| Brand | Bdenza |
| No of Capsules | 112 Capsules |
Additional Information:
View Complete details
| Composition | Pomalidomide |
| Manufacturer | Natco |
| Packaging Size | 21 Capsule |
| Brand | Pomalid |
| Dosage Form | Oral |
| Dose/Strength | 4 mg |
View Complete details
Minimum Order Quantity: 2 Box
| Manufactured By | Astrazeneca |
| Composition | Anastrezol |
| Gender | Female |
| Dose/Strength | 1mg |
| Form of Medicine | Tablets |
| No of tablets | 28 |
Additional Information:
View Complete details
Minimum Order Quantity: 2 Vial
| Strength | 100 mg |
| Form | Vial |
| Packaging Type | Vial |
| Storage Condition | Store in a refrigerator at (2 DegreeC to 8 DegreeC). Do not freeze. |
Infliximab, a chimeric monoclonal antibody, sold under the brand name Remicade among others, is a medication used to treat a number of autoimmune diseases. This includes Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, and Behçet's disease.[22] It is given by slow injection into a vein, typically at six- to eight-week intervals.[22]
Common side effects include infections, acute infusion reactions, and abdominal pain.[22] Infliximab is a chimeric monoclonal antibody biologic. It seems to work by binding to and neutralizing TNF-α, preventing it from interacting with its receptors on the cell.[22] TNF-α is a chemical messenger (cytokine) and a key part of the autoimmune reaction.
Additional Information:
View Complete details
Minimum Order Quantity: 1 Box
| Strength | 150 mg |
| Packaging Size | 14 Tablets |
| Packaging Type | Box |
| Form | Tablet |
Abemaciclib, sold under the brand name Verzenio among others, is a medication for the treatment of advanced or metastatic breast cancers. It was developed by Eli Lilly and it acts as a CDK inhibitor selective for CDK4 and CDK6.[4]
It was designated as a breakthrough therapy for breast cancer by the US Food and Drug Administration (FDA) in October 2015.[5]
In September 2017, it was approved for use in the United States by the FDA for the treatment of certain breast cancers.[6]
Additional Information:
View Complete details
Minimum Order Quantity: 1 Box
| Form | Tablet |
| Prescription/Non prescription | Prescription |
Tivozanib, sold under the brand name Fotivda, is a medication used for the treatment of advanced renal cell carcinoma (kidney cancer).[3] It is an oral VEGF receptor tyrosine kinase inhibitor.[3]
The most common side effects include fatigue (tiredness), hypertension (high blood pressure), diarrhea, decreased appetite, nausea, dysphonia (voice changes), hypothyroidism, cough, and stomatitis.[4][3][5]
Tivozanib was approved for medical use in the European Union in August 2017,[4] and in the United States in March 2021
Additional Information:
View Complete details
| Packaging Size | 224Caps |
| Form | Tablet |
| Strength | 40Mg |
| Brand | GLENZA |
View Complete details
Minimum Order Quantity: 1 Box
| Strength | 150 mg/ml |
| Packaging Size | 150 Mg/ml |
| Brand | Omnirel |
| Prescription/Non prescription | Prescription |
Additional Information:
View Complete details
Minimum Order Quantity: 1 Box
| Form | Tablet |
Additional Information:
View Complete details
Minimum Order Quantity: 1 Box
| Form | Tablet |
| Prescription/Non prescription | Prescription |
Additional Information:
View Complete details
| Form | Tablet |
| Prescription/Non prescription | Prescription |
| Country of Origin | Made in India |
Tucanat 150mg Tablet is a medicine used to treat a specific type of breast cancer called HER2-positive breast cancer, especially when it has spread to other parts of the body, including the brain. It is usually given along with two other medicines—trastuzumab and capecitabine.
Tucatinib in Tucanat 150mg Tablet works by blocking a protein (HER2) that helps cancer cells grow. By doing this, Tucatinib helps slow down or stop the cancer from spreading further.
Tucatinib is not a chemotherapy drug. It is a targeted therapy, which means it attacks cancer cells more specifically and causes less harm to healthy cells. It is given only with a doctor’s advice and regular checkups are needed during treatment to make sure the medicine is working safely.
Additional Information:
View Complete details
Minimum Order Quantity: 1 Box
| Dose/Strength | 250 mg |
| Form | Tablet |
| Dose Strength (Mg) | 250 mg |
| Usage | Clinical, Hospital |
| Brand | Geftinat |
| Pack Contain | 30 Tablet |
View Complete details
Minimum Order Quantity: 2 Bottle
| Strength | 150 mg |
| Usage | Clinical, Hospital, Personal, Commercial |
| Type | Allopathic |
| Dose/Strength | 150 & 100mg |
| Brand | Erlonat |
ERLONAT is a targeted therapy. Erlonat is classified as a epidermal growth factor receptor (EGFR) inhibitor - protein-tyrosine kinase inhibitor. It works by helping to stop cancer cells from growing.
MEDICINE USES :Erlonat medicine is used for :
Erlonat works by slowing cancer cell growth. It binds to a certain protein (epidermal growth factor receptor-EGFR) in some tumors.
Strghth Available:100mg &150mg
Additional Information:
View Complete details
Minimum Order Quantity: 1 Box
| Dose/Strength | 250mg |
| Dosage Form | Tablets |
| Form of Medicine | Tablet |
| Salt | lapatinib |
| Packaging Type | 150 tab |
| Brand | Herduo |
Additional Information:
View Complete details
Minimum Order Quantity: 1 Bottle
| Generic Name | Regorefenib |
| Form | Tablets |
| Gender | Unisex |
| Dosage Form | Oral |
| Type | Allopathic |
| Usage | Commerical |
Regorafenib (Resihance) is a kinase inhibitor. It is used for treating certain patients with colorectal cancer that has spread to other parts
of the body. It is also used to treat patients with a type of stomach, bowel, or esophagus cancer called gastrointestinal stromal tumors (GIST).
Regorafenib (Resihance) is indicated for the treatment of patients with metastatic colorectal cancer (CRC) and it is also indicated for the
treatment of patients with locally advanced, unresectable or metastatic gastrointestinal stromal tumor (GIST). It may also be used for other conditions as determined by your doctor.
Additional Information:
View Complete details
| Strength | 200mg |
| Packaging Size | 3*1*4 Tablets |
| Packaging Type | Strip |
| Brand | Vorizol |
| Usage / Application | Hospital |
View Complete details
Minimum Order Quantity: 1 Box
| Prescription/Non prescription | Prescription |
| Usage | Hospital, Clinical |
| Dose | 250 mg |
| Packaging Size | 120 Tablet |
| Therapeutic Uses | Oncology |
| Brand | Abirapro |
View Complete details
| Dose/Strength | 100 mg, 100 mg |
| Packaging Size | 100 Tablet |
| Usage | Clinical |
| Type Of Medicines | Allopathic |
View Complete details
Minimum Order Quantity: 1 Pack
| Dose/Strength | 400 mg |
| Packaging Type | Bottles |
| Usage | Hospital, Personal, Clinical |
| Brand | Resof-L |
Additional Information:
View Complete details
| Dose/Strength | 500 mg |
| Type | Allopathic |
| Usage | Clinical |
| Dosage Form | Oral |
| Per Strip Contains | 10 tablets |
View Complete details
Minimum Order Quantity: 1 Box
| Brand | Xtandi |
| Dose/Strength | 40 mg |
| Usage | Hospital, Clinical |
| Medicine Type | Allopathic |
| Dosage Form | Oral |
| No of Capsules | 72 Tablets |
View Complete details
| Packaging Size | 1*4's |
| Dosage Form | Tablet |
| Dose/Strength | 200mg |
| Brand | VORIER |
| Drug Name | voriconazol |
| Usage/Application | tablets |
| Packaging Type | Strip |
Additional Information:
View Complete details
Minimum Order Quantity: 1 Box
| Strength | 150mg |
| Packaging Size | 14'S |
| Manufacturer | LILLY |
| Form | Tablet |
| Packaging Type | Box |
| Storage Condition | Store below 30 DegreeC |
| Composition | ABEMACICLIB |
| Brand | RAMIVEN |
| Treatment | oncology |
Additional Information:
View Complete details
Minimum Order Quantity: 3 Piece
| Strength | 3.6 mg |
| Packaging Type | Vial |
| Brand | ZOLADEX 3.6 |
| Manufacturer | ASTRAZENECA |
Zoladex 3.6 mg injection is a chemotherapy agent containing the active constituent Goserelin Acetate. This medicine belongs to the luteinizing hormone-releasing hormone (LHRH) agonists. In Men, it is used in combination with other medicines to treat localized prostate cancer and used alone to treat advanced prostate cancer.
In women, it is used to treat advanced breast cancer, endometriosis, and uterine fibroids. It is also used as an endometrial-thinning agent before surgery on your uterus. It also helps to treat infertility with other medicines. Inform your doctor immediately if you face any injection site injury after receiving the injection.
Zoladex 3.6 injection works by reducing testosterone hormone in men and estrogen hormone in women. Do not use this medicine if you are pregnant or breastfeeding. Inform your doctor if you have high blood pressure or heart problems, including rhythm changes. Consult your doctor if you face any mood changes like depression or anxiety when taking this medicine.
Additional Information:
View Complete details
| Dose/Strength | 200 mg |
| Dosage Form | Oral |
| Brand | Sorafenat |
| Usage | Hospital, Clinical |
| Pack Contains | 120 Tablets |
View Complete details
Minimum Order Quantity: 2 Box
| Category | Lung Cancer, cancer, Blood Cancer |
| Type | Allopathic |
| Medicine Type | Allopathic |
| Brand | Lenalid |
| Strength | 5,10,25mg |
| Dose Strength | 5,10,25mg |
| Usage | Commerical |
| Drug Name | Lenelidomide |
Lenalidomide ( Tab Lenalid 25 mg by Natco ) is an immunomodulating agent that affects the working of immune system to help the bone marrow in making new & normal blood cells & erasing the abnormal cells from the bone marrow.Lenalidomideaffects the immune system. It helps promote immune responses to prevent inflammation in the body.
Lenalidomide is also used in combination with dexamathasone to treat multiple myeloma (plasma cell cancer) in patients who have received at least one prior therapy. Lenalid is also available in 5 mg & 10 mg strength.
Additional Information:
View Complete details
| Dose/Strength | 500 mg |
| Dosage Form | Oral |
| Brand | Cipla |
| Per Strip Contains | 10 tablets |
View Complete details
Minimum Order Quantity: 2 Piece
| Dose/Strength | 5 mg |
| Packaging Type | Box |
| Usage | Clinical, Hospital, Personal, Commercial |
| Manufacturer | Natzol |
| Form of Medicine | Injection |
Additional Information:
View Complete details
Minimum Order Quantity: 2 box
| Dose/Strength (ex. 1 mg or 1 ml) | 40 mg |
| Usage | Clinical, Hospital |
| Brand | Nublexa |
| Dosage Form | Oral |
Additional Information:
View Complete details
Minimum Order Quantity: 2 Piece
| Number of Syringe | 1 Pre-Filled Syringe |
| Brand | Fragmin |
| Manufacturer Name | Pfizer |
| Prescription/Non Prescription | Prescription |
FRAGMIN Injection (dalteparin sodium injection) is a sterile, low molecular weightheparin. It is available in single-dose, prefilled syringes preassembled with a needle guard device, and multiple-dose vials. With reference to the W.H.O. First International Low Molecular Weight Heparin Reference Standard, each syringe contains either 2,500, 5,000, 7,500, 10,000, 12,500, 15,000 or 18,000 anti-Factor Xa international units (IU), equivalent to 16, 32, 48, 64, 80, 96 or 115.2 mg dalteparin sodium, respectively. Each multiple-dose vial contains either 10,000 or 25,000 anti-Factor Xa IU per 1 mL (equivalent to 64 or 160 mg dalteparin sodium, respectively), for a total of 95,000 anti-Factor Xa IU per vial.
Each prefilled syringe also contains Water for Injection and sodium chloride, when required, to maintainphysiologicionic strength.
View Complete details
Minimum Order Quantity: 1 Pack
| Form | Vial |
| Packaging Type | Vial |
| Storage Condition | Store at Refrigerator at 2 DegreeC to 8 DegreeC . Do not Freeze. |
Amivantamab, sold under the brand name Rybrevant, is a bispecific monoclonal antibody used to treat non-small cell lung cancer.[4][5][6][7] Amivantamab is a bispecific epidermal growth factor (EGF) receptor-directed and MET receptor-directed antibody. It is the first treatment for adults with non-small cell lung cancer whose tumors have specific types of genetic mutations: epidermal growth factor receptor (EGFR) exon 20 insertion mutations.[5]
The most common side effects include rash, infusion-related reactions, skin infections around the fingernails or toenails, muscle and joint pain, shortness of breath, nausea, fatigue, swelling in the lower legs or hands or face, sores in the mouth, cough, constipation, vomiting and changes in certain blood tests.[5][6]
Amivantamab was approved for medical use in the United States in May 2021,[5][6][8][9] and in the European Union in December 2021.[7] The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication.[10]
Additional Information:
View Complete details